Showing results (541-550 of 881) with videos related to

Sort By:
Pageof 89
European Journal of Internal Medicine|June 19, 2007
STAT1 and STAT3 as intracellular regulators of vascular remodelingAndrzej Wincewicz, Mariola Sulkowska, Ryszard Rutkowski, et al.
The American Journal of Gastroenterology|August 8, 2008
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administrationHerbert L Bonkovsky, Alan D Tice, Rockford G Yapp, et al.
Psychology in the Schools|November 9, 2020
The Affective Lives of Doubled-Up Latinx Youth: Influences of School Experiences, Familism, and Ethnic Identity ExplorationLorena Aceves, Amanda M Griffin, Michael L Sulkowski, et al.
Antiviral Therapy|September 8, 2012
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detectionJill Hochreiter, Jill Lapham, Flossie Wong-Staal, et al.
Anticancer Research|May 1, 2001
Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignanciesJ Brockmann, C Emparan, C A Hernandez, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 14, 2007
Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumorKatarzyna Jarzabek, Pascal Philibert, Mariusz Koda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trialMark S Sulkowski, Franco Felizarta, Cheryl Smith, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 13, 2006
Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infectionJohn Hornberger, Francesca J Torriani, Douglas T Dieterich, et al.
Pageof 89